FI953934A0 - Farnesyyli:proteiinitransferaasin inhibiittoreja, jotka toimivat syöpää vastaan vaikuttavina aineina - Google Patents

Farnesyyli:proteiinitransferaasin inhibiittoreja, jotka toimivat syöpää vastaan vaikuttavina aineina

Info

Publication number
FI953934A0
FI953934A0 FI953934A FI953934A FI953934A0 FI 953934 A0 FI953934 A0 FI 953934A0 FI 953934 A FI953934 A FI 953934A FI 953934 A FI953934 A FI 953934A FI 953934 A0 FI953934 A0 FI 953934A0
Authority
FI
Finland
Prior art keywords
anticancer agents
protein transferase
transferase inhibitors
farnesyl protein
alkyl
Prior art date
Application number
FI953934A
Other languages
English (en)
Swedish (sv)
Other versions
FI953934A (fi
FI111369B (fi
Inventor
David Martin Stemerick
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1994/000929 external-priority patent/WO1994019357A1/en
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI953934A publication Critical patent/FI953934A/fi
Publication of FI953934A0 publication Critical patent/FI953934A0/fi
Application granted granted Critical
Publication of FI111369B publication Critical patent/FI111369B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015Esters of acyclic unsaturated acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3821Acyclic saturated acids which can have further substituents on alkyl substituted by B, Si, P or a metal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • C07F9/4012Esters of acyclic acids which can have further substituents on alkyl substituted by B, Si, P or a metal

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI953934A 1993-02-23 1995-08-22 Menetelmä yhdisteiden valmistamiseksi, jotka ovat syöpää vastaan vaikuttavia farnesyyli:proteiinitransferaasin inhibiittoreita FI111369B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2141193A 1993-02-23 1993-02-23
US2141193 1993-02-23
PCT/US1994/000929 WO1994019357A1 (en) 1993-02-23 1994-01-24 Farnesyl:protein transferase inhibitors as anticancer agents
US9400929 1994-01-24

Publications (3)

Publication Number Publication Date
FI953934A FI953934A (fi) 1995-08-22
FI953934A0 true FI953934A0 (fi) 1995-08-22
FI111369B FI111369B (fi) 2003-07-15

Family

ID=21804071

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953934A FI111369B (fi) 1993-02-23 1995-08-22 Menetelmä yhdisteiden valmistamiseksi, jotka ovat syöpää vastaan vaikuttavia farnesyyli:proteiinitransferaasin inhibiittoreita

Country Status (19)

Country Link
US (1) US5463181A (fi)
EP (1) EP0686159B1 (fi)
JP (1) JPH08509470A (fi)
KR (1) KR100305128B1 (fi)
CN (1) CN1045207C (fi)
AT (1) ATE159023T1 (fi)
AU (1) AU684071B2 (fi)
CA (1) CA2154871C (fi)
DE (1) DE69406110T2 (fi)
DK (1) DK0686159T3 (fi)
ES (1) ES2110738T3 (fi)
FI (1) FI111369B (fi)
GR (1) GR3025499T3 (fi)
HU (1) HUT72647A (fi)
IL (1) IL108694A0 (fi)
NO (1) NO306618B1 (fi)
NZ (1) NZ262585A (fi)
TW (1) TW265345B (fi)
ZA (1) ZA941099B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
FR2833266B1 (fr) * 2001-12-11 2004-10-22 Mayoly Spindler Lab Nouveaux derives phosphonates, leur procede de preparation, leur utilisation comme modulateurs de l'activite des lymphocytes tgamma9 delta2
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57142993A (en) * 1981-02-28 1982-09-03 Sagami Chem Res Center 2-hydroxyphosphonic diester
DE3313070A1 (de) * 1983-04-12 1984-10-18 Bayer Ag, 5090 Leverkusen Chlorierte phosphorylmethylcarbonyl-derivate, verfahren zu ihrer herstellung und ihre verwendung in pflanzenschutmitteln
DE3425701A1 (de) * 1984-07-12 1986-01-16 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von chlorierten phosphorylmethylcarbonyl-derivaten und neue zwischenprodukte zu ihrer herstellung
US4924024A (en) * 1988-01-11 1990-05-08 E. R. Squibb & Sons, Inc. Phosphorus-containing squalene synthetase inhibitors, new intermediates and method
US5177239A (en) * 1989-07-18 1993-01-05 E. R. Squibb & Sons, Inc. Method for preparing a phosphonic acid ester
US5298655A (en) * 1991-09-27 1994-03-29 Merck & Co., Inc. Farnesyl pyrophosphate analogs

Also Published As

Publication number Publication date
CA2154871A1 (en) 1994-09-01
KR100305128B1 (ko) 2001-11-22
IL108694A0 (en) 1994-05-30
US5463181A (en) 1995-10-31
CN1045207C (zh) 1999-09-22
GR3025499T3 (en) 1998-02-27
AU6232494A (en) 1994-09-14
NO953292D0 (no) 1995-08-22
HU9502455D0 (en) 1995-10-30
NO306618B1 (no) 1999-11-29
CN1118166A (zh) 1996-03-06
FI953934A (fi) 1995-08-22
NO953292L (no) 1995-08-22
ATE159023T1 (de) 1997-10-15
EP0686159B1 (en) 1997-10-08
TW265345B (fi) 1995-12-11
HUT72647A (en) 1996-05-28
ZA941099B (en) 1994-08-30
CA2154871C (en) 1998-04-07
DK0686159T3 (da) 1998-01-26
AU684071B2 (en) 1997-12-04
EP0686159A1 (en) 1995-12-13
JPH08509470A (ja) 1996-10-08
DE69406110T2 (de) 1998-05-14
FI111369B (fi) 2003-07-15
ES2110738T3 (es) 1998-02-16
NZ262585A (en) 1997-12-19
DE69406110D1 (de) 1997-11-13

Similar Documents

Publication Publication Date Title
NO961133D0 (no) Hydroksysubstituerte azetidinonforbindelser som kan anvendes som hypokolesterolemiske midler
ATE287390T1 (de) Kalzium-rezeptor aktive verbindungen
DK0686159T3 (da) Farnesyl-proteintransferaseinhibitorer som anticancermidler
DK0686142T3 (da) Polyaminderivater som radioprotektive midler
PT861837E (pt) Novos compostos de 2-amino-indano processo para a sua preparacao e as composicoes farmaceuticas que os contem
AR247750A1 (es) Sistema inhibidor de polimerizacion y composicion estabilizada que lo comprende.